CARIBOU BIOSCIENCES INC's ticker is and the CUSIP is 142038108. A total of 147 filers reported holding CARIBOU BIOSCIENCES INC in Q4 2023. The put-call ratio across all filers is 0.55 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $64,125 | +181.8% | 39,101 | +783.2% | 0.00% | 0.0% |
| Q1 2024 | $22,755 | -81.0% | 4,427 | -78.9% | 0.00% | 0.0% |
| Q4 2023 | $119,952 | +245.8% | 20,934 | +188.5% | 0.00% | 0.0% |
| Q3 2023 | $34,684 | +18.8% | 7,256 | +5.6% | 0.00% | 0.0% |
| Q2 2023 | $29,202 | +153594.7% | 6,871 | +88.1% | 0.00% | 0.0% |
| Q1 2023 | $19 | -67.2% | 3,653 | -60.7% | 0.00% | -50.0% |
| Q4 2022 | $58 | -100.0% | 9,287 | -31.5% | 0.00% | 0.0% |
| Q3 2022 | $143,000 | +741.2% | 13,557 | +341.9% | 0.00% | – |
| Q2 2022 | $17,000 | -60.5% | 3,068 | -34.5% | 0.00% | – |
| Q1 2022 | $43,000 | +7.5% | 4,681 | +76.0% | 0.00% | -100.0% |
| Q4 2021 | $40,000 | +263.6% | 2,660 | +466.0% | 0.00% | – |
| Q3 2021 | $11,000 | – | 470 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 544,196 | $5,741,000 | 19.52% |
| Elmwood Wealth Management, Inc. | 2,364,240 | $24,943,000 | 12.45% |
| 72 Investment Holdings, LLC | 474,067 | $5,001,000 | 3.96% |
| PFM Health Sciences, LP | 6,000,000 | $63,300,000 | 2.29% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 257,892 | $2,716,000 | 0.87% |
| Avidity Partners Management LP | 3,172,600 | $33,471,000 | 0.68% |
| Rokos Capital Management LLP | 1,907,509 | $20,811,000 | 0.62% |
| Green Alpha Advisors, LLC | 69,376 | $732,000 | 0.62% |
| Nelson Capital Management, LLC | 85,020 | $897,000 | 0.26% |
| Tekla Capital Management LLC | 567,147 | $5,983,000 | 0.24% |